Drug
VCT220 clinical trials
Also written VCT220.
Keep track of what changes. Save the VCT220 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
- VCT220
- 4
Studies by the year they started
6 studies that test it; most in 2025 (2)
| Year | Studies |
|---|---|
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 0
Vincentage Pharma Co., Ltd (6)
Studies
Open first, then newest update. How each study uses VCT220 is read from its arms, and is right about nine times in ten.
Testing it · 6
- A Study of VCT220 Tablets in Adults With Type 2 Diabetes and Inadequate Blood Glucose ControlNot yet recruitingPhase 2Vincentage Pharma Co., LtdNCT07872436Written as VCT220 tablets
- A Study of VCT220 in Participants With Hypertension and Obesity or OverweightActive, not recruitingPhase 2Vincentage Pharma Co., LtdNCT07360275Written as VCT220 Tablet
- A Research Study of VCT220 in Adult Chinese Participants With ObesityCompletedPhase 3Vincentage Pharma Co., LtdNCT06939296Written as VCT220
- A Pharmacokinetic Study of VCT220 With Moderate Renal Impairment PatientsCompletedPhase 1Vincentage Pharma Co., LtdNCT07347808Written as VCT220
- A Pharmacokinetic Study of VCT220 in Particicants With Hepatic Injury and Normal Hepatic FunctionCompletedPhase 1Vincentage Pharma Co., LtdNCT06938529Written as VCT220
- A Study to Evaluate the Efficacy and Safety of VCT220 in Obesity Chinese PopulationCompletedPhase 2Vincentage Pharma Co., LtdNCT06569355Written as VCT220